ASAPF (Aurora Spine) Beginning Cash Position: $0.90 Mil (As of Mar. 2026)


ASAPF Aurora Spine Corp ASAPF
39 GF Score
Price $0.18
GF Value $0.22
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Aurora Spine Beginning Cash Position?

Aurora Spine ASAPF 39 Beginning Cash Position is $0.90 Mil as of Mar. 2026. GuruFocus rates ASAPF with a GF Score™ of 39/100 and a GF Value™ of $0.22 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Aurora Spine's Beginning Cash Position for the quarter that ended in Mar. 2026 was $0.90 Mil.

Aurora Spine's quarterly Beginning Cash Position increased from Sep. 2025 ($0.58 Mil) to Dec. 2025 ($0.67 Mil) and increased from Dec. 2025 ($0.67 Mil) to Mar. 2026 ($0.90 Mil).

Aurora Spine's annual Beginning Cash Position increased from Dec. 2023 ($0.42 Mil) to Dec. 2024 ($0.77 Mil) and increased from Dec. 2024 ($0.77 Mil) to Dec. 2025 ($0.83 Mil).

Aurora Spine Beginning Cash Position Related Terms

Aurora Spine Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Aurora Spine's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aurora Spine Beginning Cash Position Chart

Aurora Spine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.71 3.17 0.42 0.77 0.83

Aurora Spine Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.83 0.49 0.58 0.67 0.90
ASAPF
39GF Score
Aurora Spine Corp ASAPF
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aurora Spine Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $0.90 Mil mean?
Aurora Spine (ASAPF) has a Beginning Cash Position of $0.90 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Aurora Spine and its competitors.
Is Aurora Spine's Beginning Cash Position too high?
Aurora Spine's current Beginning Cash Position is $0.90 Mil. Overall, Aurora Spine has a GF Score™ of 39/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aurora Spine's Beginning Cash Position compare to ABT and SYK?
Aurora Spine's Beginning Cash Position of $0.90 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Aurora Spine and its competitors. Aurora Spine's current Beginning Cash Position is $0.90 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Spine stock overvalued right now?
Based on GuruFocus' analysis, Aurora Spine (ASAPF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.22, compared to a current price of $0.18 — trading 20.5% below its estimated fair value. The current Beginning Cash Position is $0.90 Mil. Aurora Spine's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Aurora Spine (ASAPF), the current Beginning Cash Position is $0.90 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aurora Spine (ASAPF) Overvalued in 2026?

Based on GuruFocus' analysis, Aurora Spine stock appears to be undervalued. The current stock price of $0.18 is trading 20.5% below its estimated GF Value™ of $0.22. GuruFocus considers Aurora Spine to be Modestly Undervalued.

Key valuation signals for ASAPF:

  • Beginning Cash Position: $0.90 Mil
  • GF Value™: $0.22 vs. price of $0.18 (20.5% below fair value)
  • GF Score™: 39/100 with 4 warning signs

No single metric tells the full story. See the ASAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aurora Spine Business Description

Other Exchanges ASG:Canada
Address 20 Holly Street, Suite 300, Toronto, ON, CAN, M4S 3B1
Aurora Spine Corp is engaged in the development, manufacture, and sale of minimally invasive, interspinous fusion systems and devices. These 510K and patent protected medical devices improve patient outcomes in the area of spine and sacroiliac joint surgical procedures. The company is focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies.
39GF Score

Get the complete analysis for ASAPF

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.18
Price
$0.22
GF Value